MONTREAL -- Doctors who scored poorly on the patient-physician communications and clinical decision-making portions of a clinical skills exam were significantly more likely to be the targets of patient complaints to medical authorities than fair or good communicators.
SEOUL, South Korea -- Lung cancer patients with bone metastases may live longer when treated with bisphosphonates, a study reported here suggests.
SEOUL -- Some patients with malignant mesothelioma may have a prognosis that's not quite so grim as widely believed, a Nordic collaborative group reported here.
SEOUL, South Korea -- While, overall, women with advanced stage lung cancer tend to live longer than men, the same is not true for premenopausal women, researchers found.
VIENNA -- Time and more patients shrank the 18% three-year statistically significant risk of mortality for drug-eluting coronary stents, compared with bare-metal devices, to a non-significant 1% at four years, Swedish registry researchers reported here today.
The 4th International AIDS Society Conference on HIV Pathogenesis, Treatment, and Prevention was held in Sydney, Australia, July 22 to 25, 2007
Two years ago, while revisiting the quality and durability of highly active antiretroviral therapy-linked immune reconstitution, I noted that the incidence of certain non-AIDS-defining malignancies associated with sexually transmitted viruses in immunosuppressed persons, including penile, oral, and anal cancers, have continued to increase among HIV-infected persons despite the use of highly active antiretroviral therapy
A previously healthy 43-year-old man was referred to the hospital for the diagnosis of a nodular lesion in the mandibular gingiva.
Oral cavity lymphoma occurs frequently in HIV-positive patients, often with a poor prognosis.1 Ortega and colleagues2 present an enlightening case of a destructive oral plasmablastic lymphoma in a 43-year-old HIV-positive man. Similar to another recently reported case,3 this lymphoma was their patient's first manifestation of his underlying HIV infection.
Thinking about the potential use of a vaccine to control or eliminate the spread of HIV has been present since the earliest days of the epidemic.
Tens of thousands of persons with HIV/AIDS have seen their treatment interrupted by the worldwide recall of Roche Pharmaceuticals’ protease inhibitor Viracept (nelfinavir).
We conducted a survey of 154 inmates of the Rhode Island Department of Corrections jail regarding HIV risk, HIV testing experiences, and attitudes toward rapid HIV testing in the correctional setting.
Treatment of HIV infection reduces the risk of transmission and can significantly improve patients’ quality of life. For these reasons, the CDC has recommended routine screening for HIV in all health care settings.1 HIV testing access in correctional facilities is the weakest link in the fight against HIV infection in the United States; increasing access to testing would improve the identification of HIV-positive inmates as they pass through prisons and jails, providing an opportunity to integrate them into the public health infrastructure of HIV care. However, numerous logistical and cost-related barriers to such testing must be addressed when determining how and when it should be conducted.
Two girls, aged 10 and 17 years, both with perinatally acquired HIV infection, participated in a 12-week, hospital-based exercise rehabilitation program of progressive resistance exercise training with an aerobic component.
Miller1 reports the results of a 3-month program of progressive resistance and aerobic exercise training in 2 perinatally HIV-infected girls: a normal-weight 10-year-old and an overweight 17-year-old. By the end of the program, both had decreases in body mass index (BMI); lost fat, including visceral fat, by at least some measures; and gained significant muscle strength. One had improved cardiovascular fitness, and both showed further improvements after completing a home-based program after the initial 12-week program.
Chen and colleagues developed a 5-gene signature that they found to be closely associated with relapse-free and overall survival among patients with non-small-cell lung cancer (NSCLC).
In a phase 2 study, the new echinocandin anidulafungin was demon-strated to be effective in the treatment of invasive candidiasis. Additional encouraging findings have recently been reported by Reboli and coworkers, who compared anidulafungin with fluconazole in a randomized, double-blind, noninferiority trial. The study included patients 16 years or older who had invasive candidiasis; 89% had candidemia only. They were randomly assigned to receive either intravenous anidulafungin or intravenous fluconazole. After 10 days of intravenous therapy, the patients could receive oral fluconazole.
Common eye diseases such as glaucoma, cataract, and age-related macular degeneration (ARMD) (Figure) can have significant systemic ramifications. Recent studies have found that these eye diseases may herald the onset of various types of physical and mental impairment, especially in elderly persons.
A number of factors heighten the risk of parasitic infections in elderly persons, who often live in communal settings (eg, nursing homes), where they are more likely to encounter parasites, such as the scabies mite.
I enjoyed the case involving an 8-year-old boy whose hand was bitten by a copperhead snake but would point out the following inaccuracies.
